Recent achievements in CAR-T cell immunotherapy for glioblastoma treatment
Glioblastoma remains the most common and aggressive primary brain tumor today. Because of the neuroanatomical location of glioblastoma, conventional chemotherapy and radiation therapy have limited efficacy in patients with these tumors. Over the past decade, antitumor immunotherapy has become widesp...
Guardado en:
Autores principales: | S. V. Timofeeva, A. O. Sitkovskaya, I. A. Novikova, M. A. Ezhova, E. P. Lysenko, O. I. Kit |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bc84923f84924863a08fac30e16a46d8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Optimizatsiya i intensifikatsiya insulinoterapii pri sakharnom diabete 2 tipa (klinicheskie rekomendatsii)
por: Ivan Ivanovich Dedov, et al.
Publicado: (2010) -
Aptamer-Conjugated Gold Nanoparticles Targeting Epidermal Growth Factor Receptor Variant III for the Treatment of Glioblastoma
por: Peng L, et al.
Publicado: (2020) -
Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies
por: Sergey Kulemzin, et al.
Publicado: (2021) -
DEVELOPMENT OF A REAL-TIME RT-PCR-BASED TEST PANEL FOR ASSESSMENT OF CYTOKINE PROFILE IN MONONUCLEAR CELLS FROM BLOOD AND SYNOVIAL FLUID IN RHEUMATOID ARTHRITIS
por: D. Yu. Trofimov, et al.
Publicado: (2014) -
Development of approaches for cellular immunotherapy of cancer patients
por: Yu. V. Gelm, et al.
Publicado: (2021)